MA30378B1 - Comprimés de dompéridone orodispersibles. - Google Patents

Comprimés de dompéridone orodispersibles.

Info

Publication number
MA30378B1
MA30378B1 MA31278A MA31278A MA30378B1 MA 30378 B1 MA30378 B1 MA 30378B1 MA 31278 A MA31278 A MA 31278A MA 31278 A MA31278 A MA 31278A MA 30378 B1 MA30378 B1 MA 30378B1
Authority
MA
Morocco
Prior art keywords
orodispersible
domperidone tablets
orodispersible domperidone
tablets
aromas
Prior art date
Application number
MA31278A
Other languages
English (en)
Inventor
Jean-Francois Cordoliani
Didier Berthoumieu
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of MA30378B1 publication Critical patent/MA30378B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRÉSENTE INVENTION CONCERNE UN COMPRIMÉ ORODISPERSIBLE COMPRENANT, EN POIDS : AU MAXIMUM 15% D'UNE SUBSTANCE THÉRAPEUTIQUEMENT ACTIVE À FAIBLE DOSE ; DE 55% À 70% DE MANNITOL AYANT UNE TAILLE DE PARTICULE COMPRISE ENTRE 30 µM ET 300 µM ; AU MOINS 2% DE MALTODEXTRINE ; DE 3,5% À 8% DE CROSCARMELLOSE SODIQUE ; DE 10% À 20% DE CELLULOSE MICROCRISTALLINE ; DE 0,5% À 1,5% DE STÉARATE DE MAGNÉSIUM ; ET DE 1% À 5% D'UN OU PLUSIEURS ARÔMES ET ÉDULCORANTS.
MA31278A 2006-03-15 2008-10-08 Comprimés de dompéridone orodispersibles. MA30378B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0602253A FR2898492B1 (fr) 2006-03-15 2006-03-15 Comprimes orodispersibles de domperidone

Publications (1)

Publication Number Publication Date
MA30378B1 true MA30378B1 (fr) 2009-05-04

Family

ID=37580660

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31278A MA30378B1 (fr) 2006-03-15 2008-10-08 Comprimés de dompéridone orodispersibles.

Country Status (30)

Country Link
US (1) US8852633B2 (fr)
EP (1) EP2007384B1 (fr)
JP (1) JP5184383B2 (fr)
KR (1) KR101468750B1 (fr)
CN (1) CN101394850B (fr)
AR (1) AR059852A1 (fr)
AT (1) ATE435016T1 (fr)
AU (1) AU2007224419B2 (fr)
BR (1) BRPI0708880A2 (fr)
CA (1) CA2645629C (fr)
CY (1) CY1109405T1 (fr)
DE (1) DE602007001465D1 (fr)
DK (1) DK2007384T3 (fr)
ES (1) ES2328532T3 (fr)
FR (1) FR2898492B1 (fr)
HK (1) HK1125848A1 (fr)
IL (1) IL193878A (fr)
MA (1) MA30378B1 (fr)
MX (1) MX2008011835A (fr)
NO (1) NO20084276L (fr)
NZ (1) NZ571772A (fr)
PL (1) PL2007384T3 (fr)
PT (1) PT2007384E (fr)
RU (1) RU2449793C2 (fr)
SI (1) SI2007384T1 (fr)
TN (1) TNSN08349A1 (fr)
TW (1) TWI389708B (fr)
UA (1) UA92077C2 (fr)
WO (1) WO2007104771A1 (fr)
ZA (1) ZA200808274B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009534459A (ja) 2006-04-26 2009-09-24 ローズモント・フアーマシユーテイカルズ・リミテツド 液体経口組成物
FR2909877B1 (fr) * 2006-12-13 2009-07-10 Galenix Dev Soc Par Actions Si Composition pharmaceutique contenat de la 5-chloro-1-[1-[3- (2-oxo-2,3-dihydro-1h-benzimidazol-1-yl)propyl] piperidin-4-yl]-1,3-dihydro-2h-benzimidazol-2-one et son procede de preparation
JP2009114113A (ja) * 2007-11-06 2009-05-28 Nipro Corp 口腔内崩壊錠及びその製造方法
PL2238974T3 (pl) 2009-04-09 2013-09-30 E Pharma Trento S P A Granulat do stosowania w preparatach tabletek ulegających rozpadowi w ustach
JP2010241760A (ja) * 2009-04-09 2010-10-28 Takada Seiyaku Kk 不快な味の軽減された口腔内速崩壊錠及びその製造方法
KR20130009553A (ko) * 2011-07-15 2013-01-23 한미약품 주식회사 몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 캡슐 제제
CN104127390B (zh) * 2014-08-05 2016-05-11 孙丽华 一种多潘立酮片及其制备工艺
CN106236727B (zh) * 2016-08-30 2018-11-09 林州中农颖泰生物肽有限公司 一种安乃近泡腾片及其制备方法
US20230346695A1 (en) * 2020-09-29 2023-11-02 Millicent Pharma Limited Orodispersible formulations
CN112656690A (zh) * 2021-01-29 2021-04-16 南京科技职业学院 一种适用于固体原料分散制粒的制药工艺方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
KR100481583B1 (ko) * 1996-06-14 2005-07-12 교와 핫꼬 고교 가부시끼가이샤 구강내에서빠르게붕괴하는정제
US8071128B2 (en) * 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
PT914818E (pt) * 1996-06-14 2005-08-31 Kyowa Hakko Kogyo Kk Comprimido de desintegracao rapida por via intraoral
CN100379407C (zh) * 1997-12-19 2008-04-09 史密丝克莱恩比彻姆公司 生产咀嚼分散片的方法
AU3574500A (en) 1999-03-25 2000-10-16 Yuhan Corporation Rapidly disintegrable tablet for oral administration
KR20010006835A (ko) 1999-03-25 2001-01-26 김선진 경구용 속붕해정
SK287869B6 (sk) * 1999-08-03 2012-02-03 Icos Corporation Beta-carboline pharmaceutical compositions
AR030630A1 (es) * 2000-09-11 2003-08-27 Novartis Ag Composiciones farmaceuticas
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
FR2858556B1 (fr) * 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation

Also Published As

Publication number Publication date
RU2008139969A (ru) 2010-04-20
AU2007224419B2 (en) 2012-12-20
EP2007384B1 (fr) 2009-07-01
US20090081288A1 (en) 2009-03-26
US8852633B2 (en) 2014-10-07
ZA200808274B (en) 2009-08-26
CN101394850B (zh) 2013-05-29
TW200812644A (en) 2008-03-16
FR2898492B1 (fr) 2008-06-06
TWI389708B (zh) 2013-03-21
UA92077C2 (uk) 2010-09-27
CA2645629C (fr) 2014-04-29
WO2007104771A1 (fr) 2007-09-20
MX2008011835A (es) 2008-09-29
PT2007384E (pt) 2009-08-25
CY1109405T1 (el) 2014-07-02
RU2449793C2 (ru) 2012-05-10
BRPI0708880A2 (pt) 2011-06-14
TNSN08349A1 (en) 2009-12-29
HK1125848A1 (en) 2009-08-21
AU2007224419A1 (en) 2007-09-20
ATE435016T1 (de) 2009-07-15
JP2009530244A (ja) 2009-08-27
NZ571772A (en) 2010-06-25
AR059852A1 (es) 2008-04-30
PL2007384T3 (pl) 2009-12-31
SI2007384T1 (sl) 2009-12-31
DK2007384T3 (da) 2009-09-07
KR101468750B1 (ko) 2014-12-03
ES2328532T3 (es) 2009-11-13
EP2007384A1 (fr) 2008-12-31
CA2645629A1 (fr) 2007-09-20
KR20080111473A (ko) 2008-12-23
NO20084276L (no) 2008-11-26
DE602007001465D1 (de) 2009-08-13
IL193878A (en) 2011-02-28
CN101394850A (zh) 2009-03-25
JP5184383B2 (ja) 2013-04-17
FR2898492A1 (fr) 2007-09-21

Similar Documents

Publication Publication Date Title
MA30378B1 (fr) Comprimés de dompéridone orodispersibles.
Hijnen et al. Efficacy and safety of long‐term treatment with cyclosporin A for atopic dermatitis
WO2008114800A3 (fr) Préparation solide
MA30807B1 (fr) Compositions pharmaceutiques.
ATE493972T1 (de) Gemeinsam aufbereitete mikrokristalline cellulose und zuckeralkohol als hilfsstoff für tablettenformulierungen
WO2006108075A3 (fr) Compositions et methodes accroissant la sensibilite aux medicaments et traitant les infections et maladies presentant une resistance aux medicaments
ATE396712T1 (de) Pharmazeutische zubereitung zur modifizierten freisetzung
AR033711A1 (es) Composiciones farmaceuticas
MA30064B1 (fr) Formulation a liberation prolongee comprenant l'octreotide et deux copolymeres de polylactide-glycolide ou plus
WO2006035417A3 (fr) Preparations de dihydropyrimidine
DE50307435D1 (de) Gegen missbrauch gesicherte darreichungsform
NO20074412L (no) Bruddresistente administrasjonsformer med forsinket frigiving
MX2009001294A (es) Granulo y tableta que se desintegra por vía oral que comprende oxicodona.
MY139086A (en) Use of debranched starch in extrusion-spheronization pharmaceutical pellets
WO2002028999A3 (fr) Profils d'expression genique dans les cellules granulocytaires
WO2007013666A3 (fr) Agents anti-tumeur comprenant des r-spondines
EA201100951A1 (ru) Пероральные диспергируемые таблетки
IL191804A0 (en) Solid dispersion containing an active ingredient and tablets for oral administration containing the same
TNSN08152A1 (fr) Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation
TR200604349A2 (tr) Aripiprazol içeren farmasötik bileşimler
EA201001108A1 (ru) Диспергируемые во рту таблетки, содержащие основание эсциталопрама, и способ их получения
WO2006097943A3 (fr) Compositions pharmaceutiques d'amlodipine et de benazepril.
SI1773292T1 (sl) Hitro razgradljiva oralno disperzibilna farmacevtska oblika
WO2006046114A3 (fr) Formes posologiques osmotiques a taux croissant de liberation du medicament, et leurs procedes de preparation
WO2007075980A3 (fr) Comprimes de lansoprazole se desintegrant oralement